MiR-212-3p and miR-155-5p may suppress the protective effects of CGREF1, leading to the deterioration of liver diseases like NAFLD, where maintaining hepatocyte integrity is crucial for preventing disease progression. Here, CGREF1 is linked to metabolic dysfunction-associated steatotic liver disease.